PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CD22 1,591 Target Disease Shigellosis 1,819 1 0.00 -1.00 0.00 0.60
CD22 1,591 Target Disease Cryoglobulinemia 2,693 1 0.00 -1.00 0.00 0.58
CD22 1,591 Target Disease Basal Cell Carcinoma 7,953 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Target ETS1 539 1 0.00 -1.00 0.00 0.62
CD22 1,591 Target Target Endotoxin receptor 115 1 0.00 -1.00 0.01 0.65
CD22 1,591 Target Target A1AT 329 1 0.00 -1.00 0.00 0.63
CD22 1,591 Target Disease Renal Failure 73,993 1 0.00 -1.00 0.00 0.50
CD22 1,591 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.00 0.54
CD22 1,591 Target Disease Respiratory Tract Infections 9,721 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Target BMX 185 1 0.00 -1.00 0.01 0.64
CD22 1,591 Target Disease Joint Pain 4,215 1 0.00 -1.00 0.00 0.57
CD22 1,591 Target Disease Xerostomia 3,054 1 0.00 -1.00 0.00 0.58
CD22 1,591 Target Target CD146 729 1 0.00 -1.00 0.00 0.62
CD22 1,591 Target Disease Keratitis 10,599 1 0.00 -1.00 0.00 0.54
CD22 1,591 Target Target CCL3 1,427 1 0.00 -1.00 0.00 0.60
CD22 1,591 Target Target C7 7,027 1 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Ileus 9,091 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Disease Irritable Bowel Syndrome 8,230 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Drug Alemtuzumab (Campath)- FDA 32 1 0.00 -0.98 0.03 0.67
CD22 1,591 Target Target EGF 27,487 1 0.00 -1.00 0.00 0.52